95-24511. Advisory Committee on Immunization Practices: Meeting  

  • [Federal Register Volume 60, Number 191 (Tuesday, October 3, 1995)]
    [Notices]
    [Pages 51801-51802]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-24511]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Advisory Committee on Immunization Practices: Meeting
    
        In accordance with section 10(a)(2) of the Federal Advisory 
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
    Prevention (CDC) announces the following committee meeting:
    
        Name: Advisory Committee on Immunization Practices (ACIP).
        Times and Dates: 8:30 a.m.-5:30 p.m., October 18, 1995; 8:15 
    a.m.-3:45 p.m., October 19, 1995.
        Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
    Atlanta, Georgia 30333.
        Status: Open to the public, limited only by the space available.
        Purpose: The Committee is charged with advising the Director, 
    CDC, on the appropriate uses of immunizing agents.
        Matters To Be Discussed: The Committee will discuss 
    poliomyelitis vaccinations policy; status of diphtheria in the New 
    Independent States; U.S. draft plan for diphtheria control; update 
    on rotavirus vaccine; new guidelines on pneumococcal vaccine; status 
    of measles elimination and implications for measles vaccination 
    policy; plan to revise and combine current measles/mumps/rubella 
    recommendations; national immunization survey; finalize 1996 
    recommended immunization schedule; varicella update; acellular 
    pertussis vaccine trials; summary of results of efficacy trials in 
    infants (Europe); vaccine of preference for
    
    [[Page 51802]]
    
    DTaP for 4th/5th doses; discussion of policy when DTaP is licensed 
    for infants; Lyme disease vaccine; update and status of 
    harmonization of ACIP statements and package inserts; national 
    influenza pandemic preparedness plan; risk of complications of 
    influenza during pregnancy; electronic updating of ACIP 
    recommendations; programmatic strategies to increase immunization 
    coverage: reminder/recall, immunization practice assessment and 
    feedback; and Injury Compensation Program update. Other matters of 
    relevance among the Committee's objectives may be discussed.
        Agenda items are subject to change as priorities dictate.
        Contact Person for More Information: Gloria A. Kovach, Committee 
    Management Specialist, CDC (1-B72), 1600 Clifton Road, NE, Mailstop 
    A20, Atlanta, Georgia 30333, telephone 404/639-3851.
    
        Dated: September 26, 1995.
    Carolyn J. Russell,
    Director, Management Analysis and Services Office, Centers for Disease 
    Control and Prevention (CDC).
    [FR Doc. 95-24511 Filed 10-2-95; 8:45 am]
    BILLING CODE 4163-18-M
    
    

Document Information

Published:
10/03/1995
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
95-24511
Dates:
8:30 a.m.-5:30 p.m., October 18, 1995; 8:15 a.m.-3:45 p.m., October 19, 1995.
Pages:
51801-51802 (2 pages)
PDF File:
95-24511.pdf